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Previously, we and others have shown that RhoA and
ROCK signaling are required for negatively regulating
integrin-mediated adhesion and for tail retraction of
migrating leukocytes. This study continues our inves-
tigation into the molecular mechanisms underlying
RhoA/ROCK-regulated integrin adhesion. We show that
inhibition of ROCK up-regulates integrin-mediated ad-
hesion, which is accompanied by both increased phos-
photyrosine signaling through Pyk-2 and paxillin and
inappropriate membrane protrusions. We provide evi-
dence that inhibition of ROCK induces integrin adhe-
sion by promoting remodeling of the actin cytoskeleton.
Furthermore, we find that ROCK regulates membrane
activity through a pathway involving cofilin. Inhibition
of RhoA signaling allows the formation of multiple com-
peting lamellipodia that disrupt productive migration
of monocytes. Together, our results show that RhoA/
ROCK signaling promotes migration by restricting inte-
grin activity and membrane protrusions to the leading
edge.
Circulating leukocytes respond to infection or injury by dra-
matically altering cell shape and adhesive properties to facili-
tate migration from the bloodstream to the affected tissue (1,
2). Leukocytes follow biochemical cues to guide the timing and
location of activation (3, 4). These cues include soluble inflam-
matory cytokines and chemokines as well as stationary adhe-
sion molecules. Both types of signals initiate immune system
responses from resting leukocytes and provide directional in-
formation for appropriate migration.
The process of cell migration can be described as the result of
coordination between membrane protrusive activity at a lead-
ing edge, movement of the cell body, and retraction of the rear
of the cell (5, 6). New membrane extensions at the leading edge
are stabilized by adhesive interactions between integrins and
stationary adhesion molecules located on another cell or depos-
ited as an extracellular matrix. Conversely, the retraction of
membrane at the rear of the cell requires the disruption of the
adhesive interaction either by disengagement between the li-
gand and receptor or dissociation of the links between the
integrin and the internal cytoskeleton (7).
The actin cytoskeleton plays an important role in regulating
both cell shape and adhesive properties. Actin polymerization
at the leading edge can physically drive membrane protrusion
(8). Interactions between the actin cytoskeleton and integrins
regulate integrin activity (9, 10). The links between the actin
cytoskeleton and integrins can either promote or restrain inte-
grin adhesiveness depending on the cell type and environmen-
tal context. Early investigations of integrin-actin linkages in
stationary fibroblasts demonstrated that actomyosin-depend-
ent integrin clustering was required for strong integrin adhe-
sions (11). More recently, a study of highly motile leukocytes
and lymphocytes have revealed that when these cells are cir-
culating, interactions between integrins and cortical actin can
restrain integrin activity until the appropriate signals are re-
ceived (12–15). Upon activation, the restraining integrin-actin
linkage is broken, resulting in increased integrin mobility to
allow clustering and the formation of new integrin-actin inter-
actions that promote adhesion and signaling (16, 17).
The Rho family of small GTPases regulates many facets of
cytoskeletal dynamics that underlie changes in cell shape and
adhesion during migration (18–24). These signaling proteins
act as molecular switches that are responsive to a range of
extracellular signals that influence cell migration including
those transduced by tyrosine kinase receptors, G-protein cou-
pled receptors, and integrin adhesion molecule receptors (25–
27). The targets of Rho GTPase signaling pathways modulate
actomyosin contractility through regulation of myosin phos-
phorylation and actin dynamics by either promoting polymer-
ization or by stimulating depolymerization and severing of
existing F-actin filaments (28–31).
Previously, we have investigated the role of RhoA in regu-
lating cell shape and migration properties. In fibroblasts, we
have shown that down-regulation of RhoA by p190RhoGAP is
necessary for cell spreading and directed migration into a
wound (32). In leukocytes, we have shown that RhoA signaling
to a serine/threonine kinase, ROCK,1 regulates the retraction
of the tail of migrating monocytes and negatively influences
integrin adhesion at the cell rear (33, 34). This role for RhoA
and ROCK in negative regulation of integrin adhesion was
initially unexpected based on previous findings that RhoA pro-
motes the formation of large integrin-based focal adhesions in
fibroblasts. However, these large focal adhesions are a charac-
teristic of stationary cells and are absent from leukocytes.
Instead, leukocytes form small focal complexes of tethering and
signaling molecules surrounding ligand-engaged integrins.
These focal complexes coordinate integrin signaling during mi-
gration and are present both in leukocytes and the leading edge
of migrating fibroblasts. In both cases, membrane protrusions
and their accompanying focal complexes have been shown to be
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dependent on Rac or Cdc42 and negatively regulated by RhoA
and ROCK activity (33–38).
In our current study, we have further investigated the RhoA/
ROCK signaling pathway in regulating integrin activity. We
find that ROCK negatively regulates two integrin-mediated
functions: phosphytyrosine signaling and membrane protru-
sion. We present evidence suggesting that ROCK regulates
integrin adhesion and membrane activity by suppressing cy-
toskeletal remodeling. Finally, we show that a biological con-
sequence of RhoA/ROCK signaling is to promote migration by
limiting membrane protrusions to the leading edge.
EXPERIMENTAL PROCEDURES
Cell Culture—THP-1 monocytes were routinely cultured in Dulbec-
co’s modified Eagle’s medium supplemented with 10% fetal bovine
serum and antibiotics. Transfections were carried out with 15 l of
LipofectAMINE 2000 (Invitrogen) and 1 g of DNA in 100 l of Dul-
becco’s modified Eagle’s medium in 24-well plates containing 3  105
cells for 24 h. Primary monocytes were isolated and electroporated as
described previously (24).
Plasmids, Proteins, Pharmacological Reagents, and Antibodies—
Myc-wild type cofilin, and Myc-S3A cofilin were generous gifts from
Drs. Audrey Minden and Ora Bernard. The cofilin sequences were
amplified by PCR and subcloned into a PET 28 vector for the generation
of His-tagged fusion proteins. Fusion proteins were isolated using a
His-Bind kit (Novagen) according to manufacturer’s instructions. N17
RAP1a and E63 RAP1a were a kind gift from Dr. Lawrence Quillam and
were subsequently subcloned into an enhanced green fluorescent pro-
tein N1 vector by Dr. William Arthur. GST and GST-C3 fusion proteins
were prepared as described previously (34). Cytochalasin D, latrunculin
A, jasplakinolide, and Y-27632 were purchased from Calbiochem. Con-
centrations of cytochalasin D and latrunculin A are indicated in the
text. Jasplakinolide was used either at 1 or 10 M, each concentration
giving equivalent results. Y-27632 was used at 10 M. Recombinant
human ICAM-1, VCAM, and MCP-1 were purchased from R&D Sys-
tems. Human plasma fibronectin was purchased from Invitrogen.
Pyk-2, paxillin, and PY-20 antibodies from Transduction Laboratories
were used according to manufacturer’s instructions. Cofilin antibody
was purchased from Cytoskeleton Inc., and the phosphospecific cofilin
antibody was a generous gift from Dr. Jim Bamburg.
Cell Adhesion, Morphology, and Migration Assays—Adhesion to 10
g/ml ICAM-1 or VCAM was performed as described previously (34).
Cell morphology was assessed by F-actin staining with Alexa 594-
phalloidin (Molecular Probes) or by phase-contrast microscopy using a
Zeiss Axiophot microscope with either a 100 or 63 objective. Images
were obtained with a cooled CCD camera and processed in Metamorph
Imaging software (Universal Imaging) and Adobe PhotoShop. Scion
Image software (NIH) was used to quantitate cell area. For cells plated
on fibronectin, ICAMVCAM or poly-L-lysine, a minimum of 10 cells
from three separate experiments was analyzed. Cells transfected with
Myc-S3A cofilin were detected by immunostaining, and those deter-
mined to be expressing low levels of S3A cofilin were selected for the
measurement of cell area. Data were collected from three separate
transfection experiments. Time-lapse videos were recorded with Scion
Image software. Images were taken every 20 s for 15 min to record cell
behavior at a magnification of 40. Still images were further processed
in Adobe PhotoShop. Transwell assays were performed by coating the
8.0-m pore membrane with a solution of 10 g/ml ICAM-1 and 3 g/ml
VCAM (using concentrations previously shown to promote monocyte
migration) (39), placing 105 monocytes in the upper chamber and 10
ng/ml MCP-1 in the lower chamber to induce migration. Primary mono-
cytes were allowed to migrate 1 h, whereas THP-1 cell migration was
assessed after 3 h. Cells adherent to the top of the Transwell filter were
removed with a cotton swab, and the number of cells attached to the
underside of the filter was counted by microscopy.
RESULTS
ROCK Limits Membrane Protrusions—Previous work has
shown that ROCK negatively influences integrin-mediated ad-
hesion in primary monocytes, eosinophils, and neutrophils (33,
34, 38). To better understand the molecular mechanism under-
lying this observation, we used the THP-1 monocytic cell line to
study the function of ROCK on integrin adhesion, membrane
activity, and leukocyte migration. THP-1 cells grow in suspen-
sion, but placing them in wells coated with the integrin sub-
strates, ICAM-1 or VCAM, induces adhesion that is up-regu-
lated 2-fold in the presence of the ROCK inhibitor Y-27632
(Fig. 1). This indicates that integrin adhesion of the THP-1 cell
line is regulated in the same manner as primary cells.
Because Y-27632-induced adhesion was correlated with a
dramatic increase in cell spreading in primary monocytes, we
examined the morphology of THP-1 cells treated with Y-27632.
For these experiments, we used F-actin staining to observe the
shape of THP-1 cells adherent to different integrin substrates.
Fibronectin represents an extracellular matrix material pres-
ent in wounds that engages several 1 integrins, whereas
ICAM-1 and VCAM are cell adhesion molecules expressed by
activated endothelial cells to recruit leukocytes through L/M2
and 41, respectively. THP-1 cells adherent to fibronectin or
ICAM  VCAM displayed a rounded appearance, although the
cells plated on ICAM  VCAM had more fine filopodial exten-
sions and more distinct punctate structures characteristic of
podosomes (Fig. 2A). To investigate the role of ROCK on mono-
cyte morphology, we allowed the cells to engage the substrates
in the presence of Y-27632. The area occupied by THP-1 cells
plated under various conditions was measured, and the aver-
age results are depicted graphically in Fig. 2B. The inhibition
of ROCK augmented cell spreading in response to integrin
engagement, particularly when plated on fibronectin. In addi-
tion to a simple increase in cell spreading, the F-actin staining
in Fig. 2A shows that inhibition of ROCK promoted excessive
membrane activity as indicated by F-actin content and numer-
ous lamellipodia around the perimeter of the cell. The up-
regulated protrusions were dependent on the integrin sub-
strates, because cells adherent to a nonspecific charged surface
(poly-L-lysine) were round and flat with no active lamellipodia
or membrane ruffling as indicated by the smooth appearance
and reduced levels of F-actin content.
These findings prompted us to determine whether integrin
signaling was similarly misregulated by the inhibition of
ROCK with Y-27632. Because tyrosine kinases are potent
mediators of integrin signaling, we examined the pattern of
tyrosine kinase signaling in THP-1 cells adherent to integrin
substrates. Fig. 3A shows localization of phosphotyrosine in
punctate structures concentrated toward the leading edge of
cells bound to fibronectin or ICAM  VCAM. THP-1 cells ad-
herent to integrin substrates in the presence of Y-27632 dis-
played multiple membrane extensions on the cell, each with a
FIG. 1. Inhibition of ROCK promotes integrin adhesion. THP-1
cells were allowed to adhere to wells coated with ICAM-1 or VCAM for
30 min in the presence or absence of Y-27632. The number of adherent
cells was determined by crystal violet staining as described previously.
Data shown represent results from triplicate wells from three separate
experiments normalized to the maximal binding achieved with the
addition of 100 ng/ml phorbol 12-myristate 13-acetate.
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concentration of phosphotryosine signal. The phosphotyrosine
content of cells bound to poly-L-lysine was significantly re-
duced, indicating that the integrin substrates initiated the
phosphotyrosine signaling. Thus, the increased membrane pro-
trusions were accompanied by phosphotyrosine signaling trig-
gered by integrin substrates.
To further explore the effect of inhibiting ROCK on tyrosine
phosphorylation signaling, we analyzed cell lysates for the
pattern of tyrosine phosphorylation by Western blot. Fig. 3B
shows that when THP-1 cells adhere to fibronectin, there is an
increase in tyrosine-phosphorylated proteins in the region of
100 and 64–70 kDa. This adhesion-induced phosphoty-
rosine signaling is further enhanced when the cells are allowed
to adhere in the presence of Y-2732. We next sought to deter-
mine the identity of specific proteins that may display in-
creased tyrosine phosphorylation when ROCK is inhibited with
Y-27632. Based on the molecular mass of the observed increase
in phosphotyrosine-containing proteins, we evaluated the phos-
phorylation status of the tyrosine kinase Pyk-2 (CADTK, Cak,
and RAFT-TK) and paxillin, which have molecular masses of
110 and 68 kDa, respectively. Again, THP-1 cells were allowed
to adhere to fibronectin for 20 min followed by immunoprecipi-
tation of Pyk-2 or paxillin and subjected to analysis of phos-
photyrosine content by Western blot. In suspension, Y-27632
decreased Pyk-2 tyrosine phosphorylation, suggesting that in-
tegrin-independent signaling to Pyk-2 requires ROCK signal-
ing. We found that the highest level of tyrosine phosphoryla-
tion for both Pyk-2 and paxillin occurred in cells adherent to
fibronectin in the presence of Y-27632 (Fig. 3C).
Actin Remodeling Is Required for Adhesion and Membrane
Protrusions—Having found that inhibition of ROCK with
Y-27632 promoted increased integrin adhesion that is accom-
panied by increases in membrane protrusions and phosphoty-
rosine signaling, we then investigated the molecular mecha-
nism responsible for increased integrin adhesion. Regulation of
integrin avidity is an important mechanism controlling of in-
tegrin adhesion in leukocytes (40). It is thought that the round
FIG. 2. Inhibition of ROCK leads to increased integrin-induced
membrane protrusions. A, THP-1 cells were plated on coverslips
coated with the indicated integrin substrates or poly-L-lysine for 40 min
prior to fixation, permeabilization, and staining for F-actin. Images
shown are representative of the cell morphology observed in a minimum
of three separate experiments. B, quantitation of cell spreading using
Scion Image software is shown as average cell area from at least 10 cells
in three separate experiments. Application of the Student’s t test yields
p  0.1 and p  0.3 for cells spread on fibronectin (FN) and
ICAMVCAM (I/V), respectively. Cells plated on PLL did not occupy
significantly different areas. FIG. 3. Inhibition of ROCK leads to increased adhesion-in-
duced phosphotyrosine signaling. A, THP-1 cells were plated on
coverslips coated with the indicated integrin substrates or poly-L-lysine
for 40 min prior to fixation, permeabilization, and staining for phospho-
tyrosine. Images shown are representative of the cell morphology ob-
served in a minimum of three separate experiments. B, THP-1 cells
were kept in a suspension or plated onto fibronectin-coated dishes for 20
min in the presence or absence of Y-27632. Total phosphotyrosine
content was assessed by Western blot. C, THP-1 cells were plated as in
B, and then Pyk-2 or paxillin were immunoprecipitated and the tyro-
sine phosphorylated status was measured by Western blot.
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circulating cells maintain integrins inactive by tethering them
to the band of cortical actin until appropriate signals are re-
ceived. Upon activation, integrins are freed from their cytoskel-
etal constraints and allowed to cluster, forming qualitatively
different connections with the actin cytoskeleton for signaling
and migration. Evidence both for and against the model of
cytoskeletal constraint has been reported, so we performed
experiments to test this model with our cell system using two
different drugs that destabilize the cytoskeleton, cytochalasin
D, and latrunculin A. Fig. 4A shows dose-dependent adhesion
of THP-1 cells to either ICAM-1- or VCAM-coated surfaces
when the cells are plated in the presence of cytochalasin D or
latrunculin A. Our results support the cytoskeletal constraint
model because both drugs stimulate adhesion to integrin sub-
strates at low doses. Thus, limited cytoskeletal destabilization
promotes adhesion, whereas completely abolishing F-actin does
not allow the formation of the subsequent cytoskeletal linkages
thought to be required for productive integrin clustering and
signaling. This is further supported by the observation that
cells plated in the presence of 0.1 M cytochalasin D displayed
a well spread morphology, whereas those plated in 1 M cy-
tochalasin D were very small and rounded (Fig. 4B).
We then asked whether the role of Y-27632 in promoting
integrin functions could be attributed to a destabilization of the
cortical actin network. To address this question, we utilized
another pharmacological reagent, jasplakinolide, which stabi-
lizes F-actin structures, thereby preventing actin remodeling.
Fig. 4C shows that jasplakinolide counteracts the effects of
Y-27632 on THP-1 cell morphology as the cells treated with
both jasplakinolide and Y-27632 are more rounded than those
treated with only Y-27632. In addition, jasplakinolide and
Y-27632 have opposite and ameliorating effects on THP-1 cells
adhesion. Jasplakinolide abolishes adhesion, Y-27632 pro-
motes adhesion, and cells plated in the presence of both drugs
show an intermediate level of adhesion (data not shown). These
results are consistent with a model in which ROCK negatively
regulates integrin function by maintaining the cortical actin
structure that constrains integrins.
ROCK Signaling Pathways That Regulate Integrin Func-
tion—Our next objective was to determine signaling pathways
downstream from ROCK that influenced integrin function in a
manner dependent upon cytoskeletal remodeling. The small
GTPase RAP1 plays an important role in up-regulating inte-
grin adhesion, especially in leukocytes (41–44). Cross-talk be-
tween members of the small GTPase superfamily is a common
regulatory mechanism, so we asked whether ROCK might ex-
ert its effect through RAP1 by examining the effect of RAP1
mutants on THP-1 cell membrane protrusions. If Y-27632 is
activating RAP-1 to stimulate integrin function, transfection
with constitutively active RAP1 should mimic the Y-27632
phenotype, whereas a dominant negative RAP1 should block
the Y-27632 effect on morphology. Fig. 5 shows that these
RAP1 mutants have little effect on the cell morphology with or
without Y-27632. In addition, we found that Y-27632 did not
increase the levels of GTP-RAP1 when cells were plated on
fibronectin (data not shown). These results indicate that RAP1
is not a component of ROCK signaling that modulates
integrin function.
Another potentially interesting candidate downstream from
ROCK is the LIM kinase to cofilin signaling pathway. ROCK
phosphorylates and activates LIM kinase, which phosphoryl-
ates and inactivates cofilin. Cofilin both depolymerizes and
severs F-actin filaments, thereby facilitating actin remodeling
(45). In this model, ROCK activity would lead to phosphoryl-
ated inactive cofilin that would tend to stabilize the existing
F-actin networks, whereas Y-27632 would lead to de-phospho-
rylated active cofilin that would promote actin remodeling.
However, LIM kinase and cofilin are regulated by additional
pathways besides ROCK. To determine the contribution of
ROCK signaling in cofilin regulation in our cell system, we first
examined the effect of Y-27632 on cofilin phosphorylation sta-
tus. We used an antibody that specifically recognizes cofilin
that is phosphorylated on serine 3 to show that in THP-1 cells
plated on fibronectin, there is a significant level of phosphoryl-
ated inactive cofilin. When cells are allowed to adhere to fi-
bronectin in the presence of Y-27632, the levels of cofilin phos-
FIG. 4. Actin remodeling is required for integrin adhesion in-
duced by ROCK inhibition. A, THP-1 cells were allowed to adhere to
ICAM-1- or VCAM-coated surfaces for 30 min in the presence of the
indicated doses of either cytochalasin D or latrinculin A. Adhesion was
measured by crystal violet staining as described previously. Results
shown are the average of triplicate wells in two separate experiments.
B, the morphology of THP-1 cells treated with either an adhesion-
inducing (0.1 M) or adhesion-blocking (1 M) dose of cytochalasin is
shown by F-actin staining. C, THP-1 cells were adherent to fibronectin-
coated coverslips in the presence of Y-27632  jasplakinolide for 30
min. Because jasplakinolide competes with phalloidin for binding to
F-actin, phase-contrast images are shown.
FIG. 5. RAP1 does not act downstream of ROCK inhibition to
promote membrane protrusions. THP-1 cells were transfected with
either GFP-N17 Rap1 or GFP-E63 RAP1 and plated Y-27632 onto
fibronectin-coated coverslips. Cell morphology was assessed by F-actin
staining, whereas transfected cells were visualized by GFP expression.
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phorylation are nearly abolished. This indicates that ROCK
plays an important role in regulating the phosphorylation and
thus activation, the status of cofilin in response to THP-1
cell adhesion.
We next used an S3A mutant of cofilin that cannot be phos-
phorylated and inactivated to examine the importance of cofilin
activity in cell shape and membrane protrusions. In THP-1
cells transfected with S3A cofilin, we found that low level
expression of activated cofilin led to a 40% increase in cell
spreading (Fig. 6B). In cells expressing high levels of activated
cofilin, F-actin structures are completely abolished, leading to
cells with a small rounded morphology (data not shown). This
finding is consistent with our previous data using cytochalasin
D and latrunculin A that showed strong dose-dependent differ-
ences on integrin function. We also examined the effect of
activated cofilin on the morphology of primary monocytes. In
these experiments, cells were loaded with either wild type or
S3A cofilin proteins by electroporation as described previously
(34). Previously, we have demonstrated that inhibiting ROCK
in primary monocytes increased membrane protrusive activity,
and because the cells are highly migratory, ROCK inhibition
results in cells with unretracted tails (34). Fig. 6C shows that
overexpression of wild type cofilin leads to a small increase in
the percentage of cells with unretracted tails (22% in controls,
34% with wild type cofilin), whereas loading the cells with
active cofilin results in a greater percentage of cells with un-
retracted tails (65%). The effect of loading primary monocytes
with active cofilin is very similar to the phenotype observed
with Y-27632 treatment (80% unretracted tails), albeit less
potent. Together, these results indicate that cofilin is inacti-
vated downstream from ROCK, which contributes to the pro-
motion of membrane protrusions and inhibition of tail
retraction.
ROCK Limits Membrane Protrusions and Promotes Directed
Migration—This study has examined the molecular mecha-
nisms underlying of membrane protrusions induced by inhibi-
tion of ROCK. Our next goal was to determine the biological
consequence of RhoA/ROCK-regulated membrane protrusions.
To study monocyte migration, we used our primary monocyte
system in which cells were loaded with C3 protein, a potent
inhibitor of RhoA, and subsequently ROCK activity. The loaded
monocytes were plated onto coverslips and their migration was
monitored by time-lapse video microscopy. Control cells loaded
with GST displayed a typical migration pattern in which the
membrane at the leading edge protrudes, the cell body moves
forward, and the rear of the cell retracts. This results in a cell
with a relatively round morphology, reflecting the balance be-
tween protrusions at the front of the cells and retraction of
membrane at the rear of the cell. To change direction, the
monocyte sends out a lamellipodial extension in an alternate
direction and the former leading edge stops protruding and
retracts (Fig. 7A). In contrast, monocytes loaded with C3 dis-
play competing membrane lamellae, pulling the cell in different
directions at the same time (Fig. 7B). Membrane activity is not
limited to a single leading edge, resulting in an elongated cell
with unregulated protrusions along the length of the cell. Thus,
RhoA activity is required to suppress membrane protrusions at
the rear of a migrating monocyte.
Monocytes in which RhoA or ROCK is inhibited have robust
lamellipodial protrusions, a behavior typically thought to pro-
mote migration. Yet over time, the C3-loaded monocytes do not
appear to be able to migrate any significant distance, despite
vigorous short term movements. To directly test whether mono-
cytes require ROCK signaling to undergo productive migration,
we used a Transwell migration assay. Primary monocytes (Fig.
8) or THP-1 cells (data not shown) were placed in the upper
chamber of a Transwell and allowed to migrate toward the
chemokine MCP-1 in the lower chamber. The dividing mem-
brane was coated with the ICAM  VCAM combination to
simulate integrin substrates normally used by monocytes for
migration. The number of cells that migrated to the lower
chamber was counted by microscopy, and the results are pre-
sented in Fig. 8. As expected, MCP-1 induced 10-fold induc-
tion of monocyte migration for control cells. When the migra-
tion assay was performed in the presence of the ROCK
inhibitor Y-27632, migration was reduced to 3-fold. Together,
these results demonstrate that RhoA/ROCK signaling is re-
quired to suppress protrusions at the rear of migrating mono-
cytes to allow productive migration.
DISCUSSION
In this study, we have extended results from previous work
examining the function of RhoA and ROCK signaling in leuko-
cyte migration. We report that RhoA and ROCK signaling are
required to limit membrane protrusions to a single leading
edge. When ROCK signaling was inhibited with Y-27632, we
found increased integrin adhesion accompanied by increased
membrane activity and up-regulated phosphotyrosine signal-
FIG. 6. Cofilin activation contributes to Y-27632-induced la-
mellipodial protrusions. A, THP-1 cells were allowed to adhere to
fibronectin-coated plates for 20 and 40 min in the presence or absence
of Y-27632. Cell lysates were analyzed by Western blot for the levels of
serine 3-phosphorylated cofilin and total cofilin. B, THP-1 cells were
transfected with Myc-tagged S3A cofilin or empty vector followed by
analysis of cell morphology by F-actin staining. Low expressing trans-
fectants were identified by Myc staining. Data shown are representa-
tive of one of three separate experiments. C, Primary monocytes were
loaded with wild type, S3A cofilin, or GFP (control) as described previ-
ously. Loaded cells were plated on coverslips for 40 min prior to fixation
and staining for F-actin. The number of cells with tails was counted in
20 individual fields in 3–5 separate experiments. Representative data
are shown.
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ing. We described an important role for cytoskeletal remodeling
in regulating integrin adhesion in experiments utilizing either
actin depolymerizing or stabilizing agents. An investigation
into the signaling pathways that influence cytoskeletal remod-
eling to regulate integrin activity revealed that both ROCK and
cofilin contribute to regulating membrane protrusions. Finally,
we showed that in the absence of RhoA/ROCK signaling, mono-
cytes send out competing lamellipodia that interfere with pro-
ductive migration.
We observed a strong correlation among increased integrin
adhesion, increased integrin-dependent phosphotyrosine sig-
naling, and inappropriate lamellipodial protrusions. We pro-
pose that the misregulated integrin engagement initiates phos-
photyrosine signaling, which promotes membrane protrusion.
Evidence for a direct link between integrin signaling and la-
mellipodia formation comes from our identification of Pyk-2
and paxillin as two proteins whose adhesion-induced tyrosine
phosphorylation levels are influenced by ROCK activity. Both
Pyk-2 and paxillin have been implicated in promoting protru-
sive activity in leukocytes and fibroblasts (46–50). This is fur-
ther supported by studies from the Cabanas laboratory show-
ing that increased Pyk-2 signaling in neutrophils treated with
C3 was downstream from integrin clustering (51). Our data
highlight a previously unappreciated role for ROCK signaling
in suppressing integrin adhesion, signaling, and membrane
protrusions away from the leading edge.
Circulating leukocytes must maintain tight regulation over
the state of integrin adhesiveness. Leukocytes inhibit integrin
function in the resting state to prevent unwarranted inflam-
matory responses but quickly activate integrin adhesion in
response to infection or injury. A rigid band of cortical actin
maintains the round shape of circulating leukocytes, and it has
been proposed that this cortical actin constrains integrin mo-
bility, rendering them unable to cluster with other integrins
(14, 40). Our data support the model for cytoskeletal remodel-
ing as a molecular mechanism that regulates integrin adhesion
in leukocytes. We found that low doses of two actin destabiliz-
ing agents, cytochalasin D and latrunculin A, promote integrin
adhesion, whereas the jasplakinolide, a F-actin stabilizing
agent, prevents adhesion.
Despite the pharmacological evidence for the role of actin
remodeling in integrin activation, the in vivo signaling path-
ways that would regulate actin dynamics have not been well
characterized. Here, we implicate ROCK in governing actin
remodeling, because inhibition of ROCK has the same effect as
low doses of actin destabilizing agents on integrin adhesion. In
addition, the combination of the ROCK inhibitor with an actin
stabilizer had counteracting effects on adhesion and membrane
protrusion. Further investigation of signaling pathways down-
stream from ROCK showed that the actin remodeling protein,
cofilin, is involved in regulating membrane protrusions in
THP-1 cells and tail retraction in primary monocytes. Cofilin is
known to promote actin remodeling by virtue of its actin sev-
FIG. 7. RhoA signaling is required
to suppress protrusions away from
the leading edge. A, primary monocytes
were loaded with either GST (control) or
C3 and plated on a glass slide, and time-
lapse images were taken every 20 s for 20
min. Selected frames show the cell behav-
ior of representative cells from a total of
35 cells in three separate experiments.
Arrows indicate the direction of migra-
tion. Note the abrupt change in the direc-
tion of the control (GST) cell in panels
5–7.
FIG. 8. ROCK signaling is required for MCP-1-induced migra-
tion. Primary monocytes were added to the upper chamber of a
Transwell and allowed to migrate for 1 h toward 10 ng/ml MCP-1 in the
lower chamber Y-27632 (see ‘‘Experimental Procedures’’ for details).
Data are plotted as fold increase in the number of cells that migrated to
the underside of the Transwell filter in the absence of MCP-1 or
Y-27632. Data show the average from duplicate wells in two separate
experiments.
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ering and depolymerizing activity (45). Furthermore, cofilin
activity has been implicated in promoting lamellipodial protru-
sions in response to growth factors (52, 53). The effects of
expressing non-phosphorylatable, activated cofilin were not as
striking as those observed with inhibition of ROCK, which
indicates a role for additional signaling molecules. These re-
sults indicate that regulation of integrin function by actin
remodeling was regulated by ROCK signaling through a path-
way involving inactivation of cofilin.
To evaluate the biological consequence of RhoA and ROCK
regulation of integrin functions, we analyzed the behavior of
primary monocytes in addition to THP-1 cells. Using time-lapse
video microscopy, we observed that inhibition of RhoA signal-
ing leads to the formation of multiple competing lamellae.
These monocytes appear to be unable to choose a leading edge
and do not appear to migrate any appreciable distance, despite
robust membrane protrusive activity. We measured the capa-
bility of the monocytes to migrate in a Transwell assay, which
demonstrated the ROCK dependence of MCP-1-induced migra-
tion. This finding is consistent with results reported by Ashida
et al. (54) that show that Y-27632 inhibits migration of THP-1
cells. Our results confirm those findings and build upon them
by implicating two integrin-dependent functions, phosphoty-
rosine signaling and membrane protrusions, as molecular
mechanisms underlying the block in directed migration.
Combining data from the present studies with that from
many different investigators and systems, we propose a model
in which spatial regulation of RhoA activity is required for
productive migration. In this model, RhoA must be actively
inhibited at the leading edge to allow lamellipodial protrusions.
This is supported by other studies in fibroblasts that show that
the inhibition of RhoA/ROCK signaling with C3, Y-27632, or
overexpression of p190RhoGAP promotes cell spreading, pro-
trusion, and polarity (32, 36). Furthermore, p190RhoGAP is
localized to sites of membrane protrusions and ruffling (55, 56).
Although RhoA must be inhibited at the leading edge, our
model also proposes that RhoA must be activated at the rear of
the cell to promote migration. Myosin-based contractility has
previously been implicated in the tail retraction of migrating
neutrophils (57), and the RhoA/ROCK signaling pathway is
known to regulate myosin phosphorylation. However, our pre-
vious studies in migrating monocytes did not reveal a major
role for myosin contractility in RhoA-dependent tail retraction.
Our current data suggest an additional mechanism that RhoA
and ROCK are required to suppress lamellipodia formation
away from the leading edge and that failure to limit membrane
activity inhibits productive migration.
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